Elysium Health Makes Great Strides with Cellular Health Supplement
Elysium Health is the brainchild of Dr. Leonard Guarente. Partnering with some of the world’s leading scientists and clinicians, the company translates advances in science and technology to create clinically-validated health products that work.
Dr. Guarente works as the director of the Paul F. Glenn Center for Biology of Aging Research at MIT in addition to his duties at Elysium Health as the company’s chief scientist. He has conducted significant research on molecular and genetic causes of aging during his career.
Elysium Health’s first supplement is Basis. The formula for Basis is based on 25 years of aging research. Basis boosts levels of NAD+ in our cells. NAD+ plays a major role in many of our cellular functions such as DNA protection and circadian rhythms. As we age, our levels of NAD+ decline and those functions can break down.
To ensure that Basis works as intended, Elysium Health put the supplement through a clinical trial. For participants who took the recommended dose of Basis over the course of several weeks, their levels of NAD+ increased by an average of 40 percent.
Basis is vegan, vegetarian, gluten- and nut- free, as well as free of any artificial colors and flavors. Thus, the supplement allows you to stick to your dietary needs while taking it.
Basis is available for purchase on Elysium Health’s website. The company sells Basis in a variety of monthly subscriptions. A regular month-to-month subscription costs $50 each month. The most popular plan is the six-month subscription to Basis for $270, which breaks down to $45 per month. You can also purchase a one-year subscription to Basis for $480, or $40 per month. Individual jars cost $60 each.
The leadership team at Elysium Health seeks to serve the broader health community. Eric Marcotulli directs the vision as the CEO of the company. Before becoming the CEO, he worked at Sequoia Capital as its youngest partner to lead growth investing in mobile technologies. Eric earned his BA from Princeton University and his MBA from Harvard Business School. Dan Alminana works as the COO of the company, in charge of the operational and financial elements of Elysium Health, having previously worked in venture capital at JP Morgan Securities, where he launched and led its Silicon Valley venture capital coverage unit.
Elysium Health is also in the process of developing new products. These focus on cognitive health, muscle function, skin health, and circadian rhythms. These products are currently in various stages of pre-clinical and clinical trials.
